Telum Therapeutics has become a member of the Spanish Bioindustry Association (Asebio), which strategically promotes the Spanish biotechnology sector and includes more than 300 companies,

Telum Therapeutics announced today the appointment of Professor Vincent A. Fischetti, that has introduced phage lysins as a new antimicrobial therapy and an alternative to

Pamplona, Spain, December 7th 2022.- Telum Therapeutics announced today that Mr. Daniel Couto has been designated to its Board of Directors as an independent director.